ArticleJAMA oncology2019

Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab.

Suzanne L Topalian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.